Immunogenicity and efficacy of one dose measles–mumps–rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age
- 30 July 2001
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 19 (31), 4473-4478
- https://doi.org/10.1016/s0264-410x(01)00207-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical immunogenicity of measles, mumps and rubella vaccine delivered by the Injex jet injector: comparison with standard syringe injectionThe Pediatric Infectious Disease Journal, 2000
- Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian childrenThe Pediatric Infectious Disease Journal, 2000
- Serologic Responses to Measles, Mumps, and Rubella (MMR) Vaccine in Healthy Infants: Failure to Respond to Measles and Mumps Components May Influence Decisions on Timing of the Second Dose of MMRCanadian Journal of Public Health, 1998
- Protective Immunity in Macaques Vaccinated with Live Attenuated, Recombinant, and Subunit Measles Vaccines in the Presence of Passively Acquired AntibodiesThe Journal of Infectious Diseases, 1997
- Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategiesJAMA, 1990
- Practice in Developing CountriesThe Lancet, 1990
- Effect of timing of measles vaccination on compliance with immunizations during the second year of lifeThe Journal of Pediatrics, 1983
- Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunizationThe Journal of Pediatrics, 1979
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977